|
|
Fixed Deadline Call - Dedicated Call - 10/00
Fixed Deadline Call - Dedicated Call
|
| "Group 1" | |
| "Note 1" chemicals | Vinyl chloride, acrylamide, epichlorohydrin |
| HVOC (halogenated volatile organic compounds) | Trichloromethane, tribromomethane, dibromochloromethane, bromodichloromethane, 1,2-dichloromethane, tetrachloroethene, trichloroethene |
| Benzene and other aromatics | |
| Polycyclic aromatic hydrocarbons | |
| Mineral Oil constituents | BTX, MTBE, TAME, ETBE |
Two additional "groups" of organic contaminants are also considered to be important. Although not specifically defined, they could be considered to fall under the Article 1 objective which states that " The objective of this Directive shall be to protect human health from the adverse effects of any contamination of water intended for human consumption by ensuring that it is wholesome and clean".
"Group 2" being : Chlorophenols , Phthalates - (including ethoxylates and nonylphenol)
"Group 3" :
Consideration will also be given to the class of parameters defined as "pesticides", although some generic grouping is given in the directive i.e. organic insecticides, herbicides, fungicides, nematocides etc. The major problem is likely to be the diversity of analytical techniques and extraction procedures required for such a wide indistinct group of organic materials. Problems will also result from the "compound mixtures" that may be required by the analytical community, to meet the specific needs of the local area (i.e. different pesticides will be used in different areas depending upon the type of agricultural practices of the region).
The selection of parameters and/or groups of substances also goes a long way to meeting a recent proposal on Priority substances in the aquatic environment from the European Parliament and a Council Decision which establishes, in the context of the Water Framework Directive, an initial list of 32 priority substances (or groups of substances) believed to pose a risk to aquatic ecosystems and consequently to human health. 4
The project will contribute to the improvement in the quality of water used for human consumption and will provide tangible evidence on traceability and comparability of data throughout the community.
The project has direct relevance to the implementation of EU Directives aimed at improving water quality. It has particular benefit to the protection of human health, the environment and to the costs related to the maintenance and improvement of water quality throughout the European community.
To quantify and to provide accurate information on the possible economic benefits arising from the project is extremely difficult, although examples of pollution incidents that have occurred indicate that in monetary terms figures such as 250billion Euros could be involved. The social impact of such incidents is also difficult to estimate with accuracy, but in the consumer society any adverse situations often lead to significant problems.
The project also considers the special situation of the Accession Countries. The participation of representative laboratories from these countries will help in their approach towards meeting the requirements of European quality standards and existing EU-legislation. The project will also provide a measure, and allow evaluation of the current situation within the EU in relation to the "state-of-the art" in water analysis. This has implications in respect to international trade relationships dealingwith the quality of water for human consumption e.g. export/import of bottled waters, efficiency of water treatment processes, etc.
The work arising from this project will have a number of scientific and technological objectives. There will need to be a thorough review of current practices used by the European analytical community for the analysis of organic pollutants in water. Data currently produced and reported to the community will require evaluation and the use of the European PT-database currently under development at BAM is seen as one of several possible ways of assessing the current stature of measurement comparability for the organic compounds specified by the Directive.
In parallel to the above study, desk research and limited practical work will be undertaken either by a reference laboratory or by a core group of expert laboratories, to obtain information on the feasibility of producing suitable matrix reference materials. Following the feasibility study, information will be obtained on the homogeneity, stability, storage conditions, packaging, etc., for the range of materials considered suitable for development into full-scale reference materials.
The work should lead to the ability to produce and certify reference materials with the following specification:
- A between sample homogeneity of < 2%
- A long term stability of > 10 years
- Certification of concentrations with uncertainties (k=2) < 5%
An addendum giving general information related to the development of CRMs in the sense of the proposal is attached.
Research in support of the development of CRMs is an objective of the Growth Programme. The modality for this research is a shared cost action on RTD (cf work programme Competitive and Sustainable Growth). The guidelines for the submission of the proposal are laid down in the Guides for Proposers.
In addition to the requirements for research on a specific topic that are laid down in the supporting document*, there are general requirements for the development of CRMs. These requirements are described below and are in addition to the general requirements for shared cost actions, as described in the guides for proposers and the model contract.
The requirements have been divided in 2 major parts:
I) Description of the work
This part concentrates on the technical requirements of the research as well as the reporting requirements in view of the future certification.
II) Implementation of the objectives of the research
The research on CRMs consists of the development of the ability to produce and certify reference materials that are fit for purpose. The planned exploitation of the results has to aim at the production and certification of the reference material(s) in accordance with prevailing international quality standards.
I) Description of the work
Research on CRMs consists of the development of the ability to produce and certify reference materials. The actual production of the CRM is not part of the research but is part of the exploitation of the result(s).
In the first phase of the research project the certification strategy should be elaborated (development of the materials and methods for characterisation), in the second phase of the research project the ability to produce and certify should be demonstrated and finally the specifications for the final CRM should be set.
The development of a CRM normally consists of 4 major parts:
1) development of the know-how required to produce (and package) the future CRM1. Development of the know-how required to produce (and package) the future CRM
2. Development of the methods needed for future certification of the material
Certification can be performed according to different criteria. The research will define which certification route, following internationally recognised quality requirements and standards, will be followed.
Certification on the basis of pure substances
Certification on the basis of preparation data
Certification on the basis of measurements - method-dependent quantities
Certification on the basis of measurements - method-independent quantities
3. Demonstration of the feasibility of the CRM production
Guidance for homogeneity and stability testing is given in the BCR Guidelines.
4. Reporting of detailed and realistic specifications for the future CRM
The reporting requirements are set in the guidelines for reporting. In addition to the Final Technical Report the coordinator should prepare an overview of all the results, as foreseen in the Technical Implementation Plan. In this report the outcome of the research that sets the boundaries for the future CRM production should be given preferably in the form of a technical data sheet. It should contain the following information:
- form / type of samples (with preference for individually packed portions for single use)
- lyophilisation and reconstitution procedures
- specify bottling, labelling, packing, storage and transport requirements
- identify any legal restrictions on the transport of such material and need for safety labelling, collect data for material safety data sheets
- magnitude of the quantity of interest (acceptable range)
- acceptable uncertainty on the certified value for an individual sample (this includes at least: acceptable uncertainty on the mean value for the entire batch, and acceptable level of inhomogeneity of the batch)
- method requirements (if the CRM is method dependent)
- acceptable magnitude of other quantities
- an estimate of the quantity of CRM that should be produced as well as an estimate of the production costs.
II) Implementation of the objectives of the research
As for all shared cost contracts the contractors are obliged to exploit the knowledge arising from the project. In the case of research on CRMs the contractors are, among others, obliged to assure that the CRM is produced and certified within a reasonable time limit (article 10 of Annex II General Conditions of model contract).
The "Technological Implementation Plan" (TIP), which has to be prepared in any RTD project of the 5th Framework Programme, shall explain the actions planned to assure that results of the project will be exploited. In case of CRMs this TIP has to outline the strategy for the CRM production, certification and marketing within a reasonable time frame, at a reasonable cost and according to internationally recognised quality requirements. A draft TIP has to be available at the project mid-term. Options, ranging from production by the consortium to production by a third party or the Commission, will be explored in consultation with the Commission Services.